BioCryst Pharmaceuticals | BCRX - Interest Income


BioCryst Pharmaceuticals reported $-0.13 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Chugai Pharma JPY 480M 465M Jun/2024
Daiichi Sankyo JPY 9.96B 230M Mar/2024
DBV Technologies USD -0.32 0.02 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 26M 24M Sep/2025
Incyte USD 33.69M 2.93M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Novavax USD 303K 27K Dec/2021
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026